Zura Bio (ZURA) Change in Account Payables (2022)

Zura Bio's (ZURA) quarterly Change in Account Payables came in at $122887.0 in Q4 2022, down 4.92% quarter-over-quarter from $129240.0 in Q3 2022.

Zura Bio (ZURA) Change in Account Payables (2022) Analysis & Trends

Zura Bio's Change in Account Payables history runs 1 years deep, the most recent figure standing at $122887.0 for Q4 2022.

On a quarterly basis, Change in Account Payables changed N/A year-over-year to $122887.0 in Q4 2022; TTM through Dec 2022 was $212272.0, a N/A change from a year earlier, with the FY2022 full-year figure at $212272.0, up 203.88% from the prior year.
Change in Account Payables eased to $122887.0 in Q4 2022 per ZURA's latest filing, from $129240.0 in the prior quarter.
Across five years, Change in Account Payables topped out at $129240.0 in Q3 2022 and bottomed at -$164292.0 in Q2 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Change in Account Payables (Qtr)
1	Oculis Holding AG	67,042.03 Bn	67,041.74 Bn	-	-
2	Nanobiotix	1,908.00 Bn	1,907.94 Bn	-	-
3	Akari Therapeutics	959.56 Bn	959.56 Bn	-	-
4	BeOne Medicines	472.89 Bn	468.10 Bn	1.35 Bn	-42.19 Mn
5	Vertex Pharmaceuticals	122.12 Bn	114.87 Bn	2.59 Bn	35.60 Mn
6	Regeneron Pharmaceuticals	70.04 Bn	61.29 Bn	3.31 Bn	-
7	Belite Bio	62.68 Bn	62.68 Bn	-	-
8	Argenx Se	55.90 Bn	50.72 Bn	1.41 Bn	-
9	Alnylam Pharmaceuticals	37.47 Bn	34.46 Bn	959.66 Mn	-
10	Zura Bio	614.42 Mn	614.42 Mn	-	-

Download Data